Staging prostate cancer and its relationship to prognosis

Diagnostic Histopathology

Volumn 16, Issue 9, 2010, Pages 432-438

  Falzarano, Sara M ^a   Magi Galluzzi, Cristina ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Prognosis; Prostate cancer; Staging

Indexed keywords

ARTICLE; BLADDER NECK; CANCER CLASSIFICATION; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL EVALUATION; CLINICAL RESEARCH; DISTANT METASTASIS; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; PRIMARY TUMOR; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; SEMINAL VESICLE;

EID: 77956190709     PISSN: 17562317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2010.06.010     Document Type: Article

References (50)

1. Damber J.E., Aus G. Prostate cancer. Lancet 2008, 371:1710-1721.
2. McAleer S.J., Schultz D., Whittington R., et al. PSA outcome following radical prostatectomy for patients with localized prostate cancer stratified by prostatectomy findings and the preoperative PSA level. Urol Oncol 2005, 23:311-317.
3. Isbarn H., Wanner M., Salomon G., et al. Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era. BJU Int 2010, 106:37-43.
4. AJCC cancer staging 2010, 525-538. Springer-Verlag, New York. 7th edn. S.B. Edge, D.R. Byrd, C.C. Comptom, A.G. Fritz, F.L. Greene, A. Trotti (Eds.).
5. Paul A., Ploussard G., Nicolaiew N., et al. Oncologic outcome after extraperitoneal laparoscopic radical prostatectomy: midterm follow-up of 1115 procedures. Eur Urol 2010, 57:267-272.
6. Touijer K., Secin F.P., Cronin A.M., et al. Oncologic outcome after laparoscopic radical prostatectomy: 10 years of experience. Eur Urol 2009, 55:1014-1019.
7. International Union Against Cancer (UICC) TNM classification of malignant tumours 2002, Wiley-Liss, New York. 6th edn. L.H. Sobin, C. Wittekind (Eds.).
8. Freedland S.J., Partin A.W., Epstein J.I., Walsh P.C. Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2b. Cancer 2004, 100:1646-1649.
9. Hong S.K., Han B.K., Chung J.S., et al. Evaluation of pT2 subdivisions in the TNM staging system for prostate cancer. BJU Int 2008, 102:1092-1096.
10. Kordan Y., Chang S.S., Salem S., et al. Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy. J Urol 2009, 182:2291-2295.
11. van Oort I.M., Witjes J.A., Kok D.E., Kiemeney L.A., Hulsbergen-Van De Kaa C.A. The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system. BJU Int 2008, 102:438-441.
12. Kausik S.J., Blute M.L., Sebo T.J., et al. Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy. Cancer 2002, 95:1215-1219.
13. Swindle P., Eastham J.A., Ohori M., et al. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 2005, 174:903-907.
14. Ayala A.G., Ro J.Y., Babaian R., Troncoso P., Grignon D.J. The prostatic capsule: does it exist? Its importance in the staging and treatment of prostatic carcinoma. Am J Surg Pathol 1989, 13:21-27.
15. Chuang A.Y., Epstein J.I. Positive surgical margins in areas of capsular incision in otherwise organ-confined disease at radical prostatectomy: histologic features and pitfalls. Am J Surg Pathol 2008, 32:1201-1206.
16. Epstein J.I., Amin M., Boccon-Gibod L., et al. Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. Scand J Urol Nephrol Suppl 2005, 216:34-63.
17. Evans A.J., Henry P.C., Van der Kwast T.H., et al. Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens. Am J Surg Pathol 2008, 32:1503-1512.
18. Ekici S., Ayhan A., Erkan I., Bakkaloglu M., Ozen H. The role of the pathologist in the evaluation of radical prostatectomy specimens. Scand J Urol Nephrol 2003, 37:387-391.
19. van der Kwast T.H. Substaging pathologically organ confined (pT2) prostate cancer: an exercise in futility?. Eur Urol 2006, 49:209-211.
20. Ohori M., Wheeler T.M., Kattan M.W., Goto Y., Scardino P.T. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 1995, 154:1818-1824.
21. Epstein J.I., Carmichael M.J., Pizov G., Walsh P.C. Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup. J Urol 1993, 150:135-141.
22. Wheeler T.M., Dillioglugil O., Kattan M.W., et al. Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. Hum Pathol 1998, 29:856-862.
23. Sung M.T., Lin H., Koch M.O., Davidson D.D., Cheng L. Radial distance of extraprostatic extension measured by ocular micrometer is an independent predictor of prostate-specific antigen recurrence: a new proposal for the substaging of pT3a prostate cancer. Am J Surg Pathol 2007, 31:311-318.
24. Greene F.L. The American Joint Committee on Cancer: updating the strategies in cancer staging. Bull Am Coll Surg 2002, 87:13-15.
25. Rodriguez-Covarrubias F., Larre S., Dahan M., et al. Invasion of bladder neck after radical prostatectomy: one definition for different outcomes. Prostate Cancer Prostatic Dis 2008, 11:294-297.
26. Srigley J.R., Humphrey P.A., Amin M.B., et al. Protocol for the examination of specimens from patients with carcinomas of the prostate gland. Arch Pathol Lab Med 2009, 133:1568-1576.
27. Ruano T., Meirelles L., Freitas L.L., Magna L.A., Ferreira U., Billis A. The significance of microscopic bladder neck invasion in radical prostatectomies: pT4 disease?. Int Urol Nephrol 2009, 41:71-76.
28. Rodriguez-Covarrubias F., Larre S., Dahan M., et al. Prognostic significance of microscopic bladder neck invasion in prostate cancer. BJU Int 2009, 103:758-761.
29. Zhou M., Reuther A.M., Levin H.S., et al. Microscopic bladder neck involvement by prostate carcinoma in radical prostatectomy specimens is not a significant independent prognostic factor. Mod Pathol 2008, 22:385-392.
30. Ohori M., Scardino P.T., Lapin S.L., Seale-Hawkins C., Link J., Wheeler T.M. The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Am J Surg Pathol 1993, 17:1252-1261.
31. Debras B., Guillonneau B., Bougaran J., Chambon E., Vallancien G. Prognostic significance of seminal vesicle invasion on the radical prostatectomy specimen. Rationale for seminal vesicle biopsies. Eur Urol 1998, 33:271-277.
32. Tefilli M.V., Gheiler E.L., Tiguert R., et al. Prognostic indicators in patients with seminal vesicle involvement following radical prostatectomy for clinically localized prostate cancer. J Urol 1998, 160:802-806.
33. Guo C.C., Pisters L.L., Troncoso P. Prostate cancer invading the rectum: a clinicopathological study of 18 cases. Pathology 2009, 41:539-543.
34. Bowrey D.J., Otter M.I., Billings P.J. Rectal infiltration by prostatic adenocarcinoma: report on six patients and review of the literature. Ann R Coll Surg Engl 2003, 85:382-385.
35. Pettus J.A., Weight C.J., Thompson C.J., Middleton R.G., Stephenson R.A. Biochemical failure in men following radical retropubic prostatectomy: impact of surgical margin status and location. J Urol 2004, 172:129-132.
36. Epstein J.I., Partin A.W., Sauvageot J., Walsh P.C. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol 1996, 20:286-292.
37. Emerson R.E., Koch M.O., Daggy J.K., Cheng L. Closest distance between tumor and resection margin in radical prostatectomy specimens: lack of prognostic significance. Am J Surg Pathol 2005, 29:225-229.
38. Babaian R.J., Troncoso P., Bhadkamkar V.A., Johnston D.A. Analysis of clinicopathologic factors predicting outcome after radical prostatectomy. Cancer 2001, 91:1414-1422.
39. Epstein J.I., Srigley J., Grignon D., Humphrey P. Recommendations for the reporting of prostate carcinoma: Association of Directors of Anatomic and Surgical Pathology. Am J Clin Pathol 2008, 129:24-30.
40. Srigley J.R., Amin M.B., Bostwick D.G., Grignon D.J., Hammond M.E. Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland: a basis for checklists. Cancer Committee. Arch Pathol Lab Med 2000, 124:1034-1039.
41. May M., Kaufmann O., Hammermann F., Loy V., Siegsmund M. Prognostic impact of lymphovascular invasion in radical prostatectomy specimens. BJU Int 2007, 99:539-544.
42. Shariat S.F., Khoddami S.M., Saboorian H., et al. Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy. J Urol 2004, 171:1122-1127.
43. Roma A.A., Magi-Galluzzi C., Kral M.A., Jin T.T., Klein E.A., Zhou M. Peritumoral lymphatic invasion is associated with regional lymph node metastases in prostate adenocarcinoma. Mod Pathol 2006, 19:392-398.
44. Ito K., Nakashima J., Mukai M., et al. Prognostic implication of microvascular invasion in biochemical failure in patients treated with radical prostatectomy. Urol Int 2003, 70:297-302.
45. Briganti A., Blute M.L., Eastham J.H., et al. Pelvic lymph node dissection in prostate cancer. Eur Urol 2009, 55:1251-1265.
46. Boormans J.L., Wildhagen M.F., Bangma C.H., Verhagen P.C., van Leenders G.J. Histopathological characteristics of lymph node metastases predict cancer-specific survival in node-positive prostate cancer. BJU Int 2008, 102:1589-1593.
47. Cheng L., Pisansky T.M., Ramnani D.M., et al. Extranodal extension in lymph node-positive prostate cancer. Mod Pathol 2000, 13:113-118.
48. Rove K.O., Crawford E.D. Metastatic cancer in solid tumors and clinical outcome: skeletal-related events. Oncology (Williston Park) 2009, 23:21-27.
49. Ryan C.J., Elkin E.P., Cowan J., Carroll P.R. Initial treatment patterns and outcome of contemporary prostate cancer patients with bone metastases at initial presentation: data from CaPSURE. Cancer 2007, 110:81-86.
50. Kattan M.W., Wheeler T.M., Scardino P.T. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999, 17:1499-1507.